Human Resources offers inclusive benefits to employees – Source

Building a more inclusive community at Colorado State University is a shared goal, and one that Human Resources embraces through offering inclusive benefits to our faculty and staff. Employees may be unaware of medical benefits, leave options and wellness programs that are designed specifically to support all gender identities and people of color.

Positive Results from VISEN’s Phase 3 Trial of Once-Weekly TransCon hGH in China Consistent with Ascendis Pharma’s Phase 3 Height Trial -…

- VISENs Phase 3 Trial achieved primary endpoint; pediatric growth hormone deficiency (GHD) patients treated with TransCon hGH demonstrated greater annualized height velocity at 52-weeks (p=0.0010) compared to patients treated with daily growth hormone - These results demonstrate the ability of TransCon technology to deliver consistent and reproducible results for patients across a broad range of geographies and populations COPENHAGEN, Denmark, May 23, 2022 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S ( ASND) announced today that results from VISEN Pharmaceuticals Phase 3 trial of once-weekly TransCon hGH in children with GHD in China demonstrated results that were consistent with the Ascendis Pharmas earlier multi-national Phase 3 trial.

Swole Is The Goal: ARod’s Girlfriend Gets A Pump In On Their Italian Vacation – OutKick

Content machines ARod and girlfriend Kathryne Padgett were at it again Monday with the slugger behind the camera as his fitness model girlfriend got swole and then jumped into ocean waters in some undisclosed location. If youve been on a vacation of your own and havent been following along, ARod rented out a ship for yet another summer vacation that includes Padgett, former NFL wide receiver Eric Decker and his wife/singer Jessie James Decker. Others have joined the fray over the last week, but these are the main actors who have been pumping out content for the tabloids.

Crinetics: Late-Stage Acromegaly Disease Studies Will Be Inflection Point (NASDAQ:CRNX) – Seeking Alpha

D-Keine/E+ via Getty Images Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a great speculative biotech play to look into. That's because it is expected that it will release results from two phase 3 studies under the PATHFNDR program in 2023.

Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program – Montreal Gazette

Breadcrumb Trail Links Author of the article: Company advancing AIM Biologicals development program as a potential therapeutic treatment option for neuromyelitisopticaspectrum disorder (NMOSD) Positive results presented at the 13thInternational Congress on Autoimmunity being held in Athens, Greece Preliminary data with mouse 2D2 models of spontaneousautoimmune encephalomyelitis (EAE) indicate that mouse-adapted AIM Biologicals may reduce optic neuritis, loss of inner nuclear layer neurons and EAE symptoms This advertisement has not loaded yet, but your article continues below. TORONTO, ONTARIO, June 13, 2022 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (Aeterna or the Company), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced its Autoimmunity Modifying (AIM) Biologicals program has achieved pre-clinical proof-of-concept for the potential treatment of neuromyelitis optica spectrum disorder (NMOSD) (also known as Devic disease), a chronic autoimmune disorder of the brain and spinal cord dominated by inflammation of the optic nerve and spinal cord and which can be fatal in approximately 30% of patients within five years of diagnosis

Ask the doctor: Should my granddaughter have her adenoids removed? – Independent.ie

Question: My three-year-old granddaughter lives in another European country and has been sick a lot lately. The doctor there has suggested that she have her adenoids removed but my son is against it as he wants more information before they get it done and there is a bit of a language barrier. She is sick a lot with viruses but arent all kids?

Hydroxyprogesterone Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2030 Indian Defence News – Indian…

Hydroxyprogesterone Market Report Coverage: Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast. Latest launched research on Global Hydroxyprogesterone Market, it provides detailed analysis with presentable graphs, charts and tables. This report covers an in depth study of the Hydroxyprogesterone Market size, growth, and share, trends, consumption, segments, application and Forecast 2030